Switch to:
More From Other Websites
[video] Health care inversions in jeopardy? Sep 29 2014
Health care inversions in jeopardy? Sep 29 2014
The Zacks Analyst Blog Highlights: Medtronic, Covidien, Abbott Laboratories, Mylan and Burger King... Sep 25 2014
Tax crackdown impact on pharma deals Sep 23 2014
[video] Tax crackdown impact on pharma deals Sep 23 2014
[video] Apple, Facebook, Goldman & JPMorgan Gain Despite Slipping Markets Sep 23 2014
Inversion Deal Crackdown Deflates Health Stocks Sep 23 2014
Vikings bar Peterson from all team activities Sep 17 2014
Vikings bar Peterson from all team activities Sep 17 2014
[$$] Gilead to Allow Cheaper Hepatitis C Drug in Developing Countries Sep 16 2014
Mylan Commences Phase III Clinical Trials for its Generic Version of Advair Diskus® and Insulin... Sep 16 2014
[video] Gilead Expands Access of Hepatitis C Drug in Developing Countries Sep 15 2014
Gilead to license generic version of Sovaldi Sep 15 2014
Gilead to license generic version of Sovaldi Sep 15 2014
Mylan Signs Agreement with Gilead to Accelerate Access to Hepatitis C Treatments, Sovaldi®... Sep 15 2014
Gilead licenses hepatitis C drug to Cipla, Ranbaxy, 5 others Sep 15 2014
ABB CEO Says Company ‘Too Big to Swallow’ in Tax Inversion Deal Sep 12 2014
The Zacks Analyst Blog Highlights: Mylan, Abbott Laboratories, Mallinckrodt, Gilead Sciences and... Sep 12 2014
Mylan to Acquire U.S. Rights to Arixtra for up to $300M Sep 11 2014
Top U.S. Senate Democrats unveil earnings stripping plan Sep 10 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK